Experts are worried about tuberculosis again
The deadly disease regained its crown as the world's biggest infectious killer in October 2022
Tuberculosis, commonly abbreviated as TB, may be on its way to becoming a global crisis, according to the United Nations. The deadly disease once again claimed its spot as the number one infectious killer globally in October of 2022, overtaking Covid-19, AFP reported. While progress was being made against the disease, the arrival of Covid in 2020 was a setback that caused cases to swell for the first time in a decade. “We went from what I honestly consider to be unbelievably slow progress, but at least progress, to a reversal," Mel Spigelman, president of the non-profit TB Alliance, told AFP in 2022.
TB is a highly contagious disease that“knows no borders,” Dr. Lucica Ditiu, executive director of the U.N.-hosted organization Stop TB Partnership, told Time. “So long as you breathe, you can still catch TB.” While antibiotics were developed to fight the disease, new strains of drug-resistant TB have evolved, causing higher rates of mortality. Approximately 3.6% of today’s new tuberculosis cases are resistant to multiple TB drugs. “There’s no biological reason that multi-drug-resistant TB can't acquire what it takes to transmit easily,” David Bishai, the director of the school of public health at the University of Hong Kong, told Time. “And so this does represent a pandemic threat.”
To fight the new strains, pharmaceutical company Johnson & Johnson developed a drug called bedaquiline that is effective against drug-resistant TB. The company also opted to not enforce secondary patents on the drug, allowing “current and future generic manufacturers” the ability to “manufacture and sell high-quality generic versions,” as long as the generic versions are “of good quality, medically acceptable,” and are only used in 134 specific low and middle-income countries, according to a J&J press release.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
What are Trump's plans for public health?
Today's Big Question From abortion access to vaccine mandates
By Devika Rao, The Week US Published